Supply AgreementSupply Agreement • February 25th, 2021 • Mannkind Corp • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 25th, 2021 Company Industry JurisdictionThis Supply Agreement (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).
EX-10.3 5 d783199dex103.htm EX-10.3 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested Under 28903 North Avenue Paine, Valencia, California 91355 USA 61 South Paramus Road, Paramus, New...Supply Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionTHIS SUPPLY AGREEMENT (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).
SUPPLY AGREEMENTSupply Agreement • November 10th, 2014 • Mannkind Corp • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 10th, 2014 Company Industry JurisdictionTHIS SUPPLY AGREEMENT (the “Agreement”) is made as of the 31st day of July, 2014 (the “Effective Date”) by and between MannKind Corporation, a Delaware corporation (“MannKind”), with its principal office and place of business at 28903 North Avenue Paine, Valencia, CA 91355, U.S.A., and Amphastar France Pharmaceuticals S.A.S., a French corporation (“AFP”), with its principal office and place of business at Usine Saint-Charles, 60590 Eragny-Sur-Epte, France (each of MannKind and AFP, a “Party” and together, the “Parties”).